Gene therapy makes a big comeback
After running into a buzzsaw of controversy over the safety of gene therapy studies, the Los Angeles Times notes that the field has made a big comeback. There are currently more than 300 gene therapy trials underway and solid evidence that the approach can help patients with Parkinson's and other lethal immune disorders. Gene therapy works by replacing the faulty genes that cause the disorders with healthy ones.
- read the The Los Angeles Times report on gene therapy
Paid Research Reports
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
- The Emerging Role of Postmarketing Clinical Research: Regulatory issues, strategic drivers and overall trends


Rate it: